RecruitingNot applicableNCT06866912
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
Studying Rare cardiomyopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Principal Investigator
- Simone Longhi, MDIRCCS Azienda Ospedaliero-Universitaria di Bologna
- Enrollment
- 750 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2023 – 2033
Study locations (1)
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06866912 on ClinicalTrials.govOther trials for Rare cardiomyopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06948344Acquirement of Clinical and Genomic Data to Diagnose in Rare Inherited CardiomyopathyYonsei University
- RECRUITINGNCT01143454Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular SystemNational Heart, Lung, and Blood Institute (NHLBI)